New flu shot for seniors put to the test
NCT ID NCT07327398
First seen Jan 11, 2026 · Last updated May 18, 2026 · Updated 23 times
Summary
This study tests a new flu vaccine in 1200 adults aged 60 and older. It aims to see how well the vaccine boosts the body's defenses against the flu and checks for any side effects. Participants will receive one shot and be monitored for 30 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Danjiangkou City Center for Disease Control and Prevention
Wuhan, Hubei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Yunxi County Center for Disease Control and Prevention
Wuhan, Hubei, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.